Investors / United States / Amzak Health
Amzak Health
Venture capital · New York, NY, United States · North America
Amzak Health is an evergreen fund that invests in private and select public life science companies, supporting portfolio companies throughout their life cycle. It invests in medtech and biotech companies developing first-in-class or best-in-class treatments addressing unmet medical needs.
Invests inHealthcare & Biotech
In its own wordsmedtechbiotechlife sciencesmedical devicestherapeuticshealthcare
Your fit with Amzak Health
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAmzak Health lists 16 checked portfolio companies on its own site and is named in 2 funding rounds, 2 of them as lead. Its most frequent entry is Series A, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 85% of its companies are based in United States. It invests most often alongside U.S. Venture Partners, Aperture Venture Partners and Lumira Ventures.
Counts come from funding rounds that name Amzak Health, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Amzak Health's whole history. Rounds on record name 2 companies; its own site lists 16. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 50% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 42th | 16 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 68th | 6% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| U.S. Venture Partners | 5 |
| Aperture Venture Partners | 4 |
| Lumira Ventures | 3 |
| Aisling Capital | 2 |
| Casdin Capital | 2 |
| Endeavour Vision | 2 |
| Hatteras Venture Partners | 2 |
| Lightstone Ventures | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1594%
- No longer answers00%
- Points to another company16%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with U.S. Venture Partners
Compare Amzak Health head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Amzak Health| Date | Company | Stage |
|---|---|---|
| 27 Apr 2026 | Series B Led | |
| 29 Jan 2025 | Series A Led |
Round details for Amzak Health
Amounts, full round histories and every co-investor in Amzak Health's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
16 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company invents and develops genetic medicines with proprietary customized vectors for retinal and pulmonary diseases. | Healthcare & Biotech | Portfolio page | ||
| BridgeBio develops medicines for genetic conditions | Healthcare & Biotech | Portfolio page | ||
| Contego Medical develops and manufactures medical devices for carotid and peripheral vascular procedures. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| HistoSonics has developed a non-invasive, sonic beam therapy platform that uses histotripsy to destroy targeted liver tumors at a sub-cellular level. | Healthcare & Biotech | Portfolio page | ||
| Impulse Dynamics develops and provides CCM therapy for heart failure patients. | Healthcare & Biotech | Portfolio page | ||
| Inspire Medical develops and provides implantable sleep apnea solutions | Healthcare & Biotech | Portfolio page | ||
| KOKO Medical Inc. develops a medical device to stop postpartum hemorrhaging. | Healthcare & Biotech | Portfolio page | ||
| Thryv Therapeutics is a clinical-stage biotechnology company advancing a portfolio of potent, selective inhibitors of serum and glucocorticoid-regulated kinase 1 (SGK1) as precision medicines for inherited channelopathies, cardiometabolic diseases and cardiomyopathies. | Healthcare & Biotech | Portfolio page | ||
| Miach Orthopaedics develops and provides the BEAR Implant to help heal torn ACLs. | Healthcare & Biotech | Portfolio page | ||
| Monte Rosa Therapeutics develops medicines by degrading proteins, including those previously considered undruggable, to treat various diseases. | Healthcare & Biotech | Portfolio page | ||
| Nervonik is developing peripheral nerve stimulation technology for chronic pain treatment. | Healthcare & Biotech | Apr 2026Series B | Funding round | |
| Neuros Medical develops and provides a device to control chronic post-amputation pain. | Healthcare & Biotech | Portfolio page | ||
| ShiraTronics develops a neuromodulation device to treat chronic migraine | Healthcare & Biotech | Portfolio page | ||
| Sound Blade Medical develops handheld histotripsy technology for non-invasive surgery | Healthcare & Biotech | Jan 2025Series A | Page + round | |
| The company develops motion-preserving technologies designed to treat degenerative disc disease while supporting the spine’s natural curvature. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- amzakhealth.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 29 Jan 2025
- Companies checked
- 16
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Amzak Health's profile as data
Pull Amzak Health's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/amzakhealth.com
# also
GET /v1/firms/amzakhealth.com/portfolio
GET /v1/firms/amzakhealth.com/coinvestors
GET /v1/firms/amzakhealth.com/news